A cluster-randomized, controlled trial of a simplified multifaceted management program for individuals at high cardiovascular risk (SimCard Trial) in Rural Tibet, China, and Haryana, India

Circulation

Volumn 132, Issue 9, 2015, Pages 815-824

  Tian, Maoyi ^a   Ajay, Vamadevan S ^b,c   Dunzhu, Danzeng ^d   Hameed, Safraj S ^b   Li, Xian ^a   Liu, Zhong ^d   Li, Cong ^a   Chen, Hao ^e   Cho, Ka Wing ^f   Li, Ruilai ^a   Zhao, Xingshan ^g   Jindal, Devraj ^c   Rawal, Ishita ^c   Ali, Mohammed K ^h   Peterson, Eric D ⁱ   Ji, Jiachao ^a   Amarchand, Ritvik ^j   Krishnan, Anand ^j   Tandon, Nikhil ^j   Xu, Li Qun ^k   Wu, Yangfeng ^a   Prabhakaran, Dorairaj ^b,c   Yan, Lijing L ^a,l   more..

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c Centre for chronic disease control (CoE CARRS)   (India)

^d TIBET UNIVERSITY   (China)

^e BEIJING HOSPITAL   (China)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g Jishuitan Orthopaedic College of Tsinghua University   (China)

^h EMORY UNIVERSITY   (United States)

ⁱ DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^j ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^k China Mobile Research Institute   (China)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

cardiovascular diseases; China; community; decision support techniques; India; prevention control

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; HYDROCHLOROTHIAZIDE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; ELECTRONIC DECISION SUPPORT SYSTEM; FEMALE; FOLLOW UP; HEALTH AUXILIARY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INDIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOBILE APPLICATION; MOBILE PHONE; MORBIDITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RURAL AREA; SELF REPORT; SIMPLIFIED MULTIFACETED CARDIOVASCULAR MANAGEMENT PROGRAM; SINGLE BLIND PROCEDURE; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT; AGED; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; DISEASE MANAGEMENT; ETHNOLOGY; INTERNATIONAL COOPERATION; MIDDLE AGED; PATIENT EDUCATION; PROCEDURES; RISK FACTOR; RURAL POPULATION;

AGED; CARDIOVASCULAR DISEASES; CHINA; CLUSTER ANALYSIS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; INTERNATIONALITY; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RISK FACTORS; RURAL POPULATION; SINGLE-BLIND METHOD; TIBET;

EID: 84940660361     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.015373     Document Type: Article

References (38)

1. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P, Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J, Lancet NCD Action Group; NCD Alliance Priority actions for the non-communicable disease crisis. Lancet 2011 377 1438 1447. doi: 10.1016/S0140-6736(11)60393-0
2. National Center for Cardiovascular Diseases China Report on cardiovascular diseases in China (2011). 2012
3. Patel V, Chatterji S, Chisholm D, Ebrahim S, Gopalakrishna G, Mathers C, Mohan V, Prabhakaran D, Ravindran RD, Reddy KS, Chronic diseases and injuries in India. Lancet 2011 377 413 428. doi: 10.1016/S0140-6736(10)61188-9
4. Reddy KS, Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr 2002 5 1A 231 237
5. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB, Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003 361 717 725. doi: 10.1016/S0140-6736(03)12655-4
6. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH, Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation 2005 112 3569 3576. doi: 10.1161/CIRCULATIONAHA.105.535922
7. Gaziano TA, Opie LH, Weinstein MC, Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006 368 679 686. doi: 10.1016/S0140-6736(06)69252-0
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 289 2560 2572. doi: 10.1001/jama.289.19.2560
9. National Vascular Disease Prevention Alliance, Guidelines for the Assessment of Absolute Cardiovascular Disease Risk 2009 Melbourne, Australia National Heart Foundation of Australia
10. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, Liu K, USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group; China Multicenter Collaborative Study of Cardiovascular Epidemiology Research Group Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006 114 2217 2225. doi: 10.1161/CIRCULATIONAHA.105.607499
11. Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, West M, Barlow A, Lewis-Boyer L, Donnelly-Strozzo M, Curtis C, Anderson K, Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes 2011 4 595 602. doi: 10.1161/CIRCOUTCOMES.111.961573
12. Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M, Varghese M, Thara R, Weiss HA, Williams P, McCrone P, Patel V, Thornicroft G, Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Lancet 2014 383 1385 1394. doi: 10.1016/S0140-6736(13)62629-X
13. Dye CJ, Williams JE, Evatt JH, Improving hypertension self-management with community health coaches. Health Promot Pract 2015 16 271 281. doi: 10.1177/1524839914533797
14. Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A, Badruddin SH, Chaturvedi N, Hypertension Research Group Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med 2009 151 593 601. doi: 10.7326/0003-4819-151-9-200911030-00004
15. Ajay VS, Tian M, Chen H, Wu Y, Li X, Dunzhu D, Ali MK, Tandon N, Krishnan A, Prabhakaran D, Yan LL, A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale. BMC Public Health 2014 14 924. doi: 10.1186/1471-2458-14-924
16. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E, 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013 29 151 167. doi: 10.1016/j.cjca.2012.11.032
17. Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology Chinese guidelines for prevention of cardiovascular diseases. Zhonghua Xin Xue Guan Bing Za Zhi 2011 39 3 22
18. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 25 Suppl 2 S49 S73. doi: 10.1161/01.cir.0000437741.48606.98
19. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular Prevention & Rehabilitation (EACPR) European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med 2012 19 403 488. doi: 10.1007/s12529-012-9242-5
20. Parker DR, Evangelou E, Eaton CB, Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Contemp Clin Trials 2005 26 260 267. doi: 10.1016/j.cct.2005.01.002
21. Carey KM, Comee MR, Donovan JL, Kanaan AO, A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. Ann Pharmacother 2012 46 688 695. doi: 10.1345/aph.1Q621
22. Force USPST Aspirin for the prevention of cardiovascular disease: U.S. Preventive services task force recommendation statement. Ann Intern Med 2009 150 396 404
23. Law MR, Wald NJ, Morris JK, Jordan RE, Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003 326 1427. doi: 10.1136/bmj.326.7404.1427
24. Pearson TA, Palaniappan LP, Artinian NT, Carnethon MR, Criqui MH, Daniels SR, Fonarow GC, Fortmann SP, Franklin BA, Galloway JM, Goff DC Jr, Heath GW, Frank AT, Kris-Etherton PM, Labarthe DR, Murabito JM, Sacco RL, Sasson C, Turner MB, American Heart Association Council on Epidemiology and Prevention American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation 2013 127 1730 1753. doi: 10.1161/CIR.0b013e31828f8a94
25. Fortmann SP, Winkleby MA, Flora JA, Haskell WL, Taylor CB, Effect of long-term community health education on blood pressure and hypertension control. The Stanford Five-City Project. Am J Epidemiol 1990 132 629 646
26. Gupta R, Deedwania P, Interventions for cardiovascular disease prevention. Cardiol Clin 2011 29 15 34. doi: 10.1016/j.ccl.2010.10.005
27. Shroufi A, Chowdhury R, Anchala R, Stevens S, Blanco P, Han T, Niessen L, Franco OH, Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health 2013 13 285. doi: 10.1186/1471-2458-13-285
28. Tang L, Patao C, Chuang J, Wong ND, Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). Am J Cardiol 2013 112 1126 1132. doi: 10.1016/j.amjcard.2013.05.064
29. Yan LL, Fang W, Delong E, Neal B, Peterson ED, Huang Y, Sun N, Yao C, Li X, MacMahon S, Wu Y, Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health 2014 14 345. doi: 10.1186/1471-2458-14-345
30. Joshi R, Chow CK, Raju PK, Raju KR, Gottumukkala AK, Reddy KS, Macmahon S, Heritier S, Li Q, Dandona R, Neal B, The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. J Am Coll Cardiol 2012 59 1188 1196. doi: 10.1016/j.jacc.2011.10.901
31. Chow CK, Joshi R, Gottumukkala AK, Raju K, Raju R, Reddy S, Macmahon S, Neal B, Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. Am Heart J 2009 158 349 355. doi: 10.1016/j.ahj.2009.05.034
32. Surka S, Edirippulige S, Steyn K, Gaziano T, Puoane T, Levitt N, Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers. Int J Med Inform 2014 83 648 654. doi: 10.1016/j.ijmedinf.2014.06.008
33. Peiris D, Praveen D, Johnson C, Mogulluru K, Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review. J Cardiovasc Transl Res 2014 7 677 691. doi: 10.1007/s12265-014-9581-5
34. Beratarrechea A, Lee AG, Willner JM, Jahangir E, Ciapponi A, Rubinstein A, The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J E Health 2014 20 75 82. doi: 10.1089/tmj.2012.0328
35. Krishnan A, Shah B, Lal V, Shukla DK, Paul E, Kapoor SK, Prevalence of risk factors for non-communicable disease in a rural area of Faridabad district of Haryana. Indian J Public Health 2008 52 117 124
36. Zhao X, Li S, Ba S, He F, Li N, Ke L, Li X, Lam C, Yan LL, Zhou Y, Wu Y, Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. Am J Hypertens 2012 25 583 589. doi: 10.1038/ajh.2012.9
37. Mackay J, Mensah GA, World Health Organization., Center for Disease Control., Myriad Editions Limited The Atlas of Heart Disease and Stroke 2004 Geneva World Health Organization
38. World Health Organization Global Status Report on Noncommunicable Diseases 2010 2011 Geneva, Switzerland World Health Organization